Putting Personalized Medicine to Work in Pancreatic Cancer

SysQuant® Global Phosphoproteomics

Goal Profile signalling pathways driving pancreatic ductal adenocarcinomas

Outcome – Analysis of 32 cases shows pathways controlling how cells interact with each other and the tumor stroma are consistently affected in all patients. However, greater heterogeneity was seen in the activity of several key drug targets highlighting the need for personalised treatments for each patient.

Collaborators King’s College Hospital

View all case studies